Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET

Company Participants

Jenny Gelinas - VP, IR

Rick Poulton - CEO

Tom Langan - President and Chief Commercial Officer

Leah Jones - CFO

Conference Call Participants

Stephanie Davis - SVB Securities

Cindy Motz - Goldman Sachs

Charles Rhyee - Cowen

Sean Dodge - RBC Capital

Michael Cherny - Bank of America

George Hill - Deutsche Bank

Jeff Garro - Piper Stanley

Dolph Warburton - Nephron Research

Operator

Ladies and gentlemen, good day, and thank you for joining us for this Allscripts Q2 2022 Earnings Conference Call. [Operator Instructions] Also a friendly reminder, today's session is being recorded.

To get us started with opening remarks and introductions, I am pleased to turn the floor over to your host, Jenny Gelinas. Go ahead please.

Jenny Gelinas

Thank you very much. Good afternoon, and welcome to the Allscripts second quarter 2022 earnings conference call. Our speakers today are Rick Poulton, Allscripts Chief Executive Officer; Tom Langan, President and Chief Commercial Officer; and Leah Jones, our Chief Financial Officer.

We will be making a number of forward-looking statements during the presentation and Q&A part of the call. These statements are based on current expectations and involve a number of risks and uncertainties that could cause our actual results to vary materially. We undertake no obligation to revise these forward-looking statements in light of new information or reasons future events. Please refer to our earnings release and SEC filings with more information regarding the risk factors that may affect our results.

Please reference the GAAP and non-GAAP financial statements as well as the non-GAAP tables in our earnings release that are available on our Investor Relations website.

And with that, I'm going to hand the call over to Rick.

Rick Poulton

Okay, thank you, Jenny, and thanks everybody for joining us for our second quarter earnings call.

I'd also like to formally extend a warm welcome to both Tom and Leah to their first earnings call. I've had the opportunity to work very closely with each of them for several years and I know that they are ready to take on the expanded roles they have now with the company.

As I mentioned on the last call, our transaction with Constellation Software closed on May 2nd. Now, while the financial transaction closed on that date, there was an incredible amount of work throughout the whole quarter to begin the process of physically separating the two companies. And I'd like to thank all the employees from both Allscripts and our foreign business now named Altera for their hard work and dedication that was required in the last three months to get that process started.